SCHEMBL7834675

SCHEMBL7834675

Nc1ccc(S(=O)(=O)Nc2cc(Cl)nc(Cl)c2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.63
PRMT1 Q99873 1/20 0.58
KMT2A Q03164 2/20 0.57
KDM4E B2RXH2 1/20 0.56
LMNA P02545 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
CA1 P00915 2/20 0.56
CA2 P00918 2/20 0.56
HTT P42858 1/20 0.56
CA9 Q16790 1/20 0.56
CDC7 O00311 1/20 0.55
EEF2K O00418 1/20 0.55
PLK4 O00444 1/20 0.55
AURKA O14965 1/20 0.55
DYRK3 O43781 1/20 0.55
RPS6KA5 O75582 1/20 0.55
PRKD3 O94806 1/20 0.55
MAP4K4 O95819 1/20 0.55
PIM1 P11309 1/20 0.55
PHKG2 P15735 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7834457 0.87 HTR6 (0.53) HTR6PRMT1KMT2AKDM4ELMNA
Hydrochloric Acid SCHEMBL7839560 0.86 HTR6 (0.80) HTR6PRMT1KDM4ELMNANPSR1
SCHEMBL3841821 0.83 PRMT1 (0.66) HTR6PRMT1KMT2AKDM4ELMNA
SCHEMBL28557305 0.81 HTR6 (0.63) HTR6PRMT1KMT2AKDM4ELMNA
SCHEMBL7836889 0.80 HTR6 (0.71) HTR6PRMT1KMT2ACA1CA2
SCHEMBL8413230 0.80 CES1 (0.44) HTR6KMT2ALMNAHTTALDH1A1
SCHEMBL7837027 0.80 HTR6 (0.85) HTR6PRMT1KMT2ACA1CA2
SCHEMBL7833559 0.80 HTR6 (0.69) HTR6PRMT1KDM4ELMNANPSR1
SCHEMBL540915 0.78 CA1 (0.85) HTR6PRMT1KMT2ACA1CA2
SCHEMBL11793140 0.78 CA1 (0.85) HTR6PRMT1KMT2ACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815861-B1 Sulphonamides and their use HOFFMANN LA ROCHE (CH) 2001-09-19 EP disclosed
US-6030976-A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; CENTRAL NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE, PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, MEMORY DISORDERS, PARKINSON'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS AND HUNTINGTON'S DISEASE HOFFMAN-LA ROCHE INC. (US) 2000-02-29 US disclosed
US-5998665-A THERAPY FOR NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-12-07 US disclosed
US-5939451-A INDOL-4-YL-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-17 US disclosed
US-5932599-A 4-AMINO-N-(PYRIDINYL-4-YL)-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-03 US disclosed
EP-0815861-A1 Sulphonamides and their use F. HOFFMANN-LA ROCHE AG (CH) 1998-01-07 EP disclosed